1. Home
  2. NVS
  3. NVS News

Latest Novartis AG (NVS) News on August 8, 2025

United States Pharmaceutical Market Forecast and Company Analysis Report 2025-2033 Featuring F. Hoffmann-La Roche, Novartis, Abbvie, Johnson & Johnson, Merck, Pfizer, BMS, Sanofi, GSK, Takeda
NVS

GlobeNewswire

a day ago

United States Pharmaceutical Market Forecast and Company Analysis Report 2025-2033 Featuring F. Hoffmann-La Roche, Novartis, Abbvie, Johnson & Johnson, Merck, Pfizer, BMS, Sanofi, GSK, Takeda

Saudi Arabia OTC Artificial Tears Market Forecast and Company Analysis Report 2025-2033 Featuring AbbVie, Akorn, Alcon, Bausch Health, J&J, Nicox, Novartis, Santen Pharmaceutical, Sun Pharmaceutical
NVS

GlobeNewswire

a day ago

Saudi Arabia OTC Artificial Tears Market Forecast and Company Analysis Report 2025-2033 Featuring AbbVie, Akorn, Alcon, Bausch Health, J&J, Nicox, Novartis, Santen Pharmaceutical, Sun Pharmaceutical

Avidity Biosciences Rockets As Novartis Reportedly Mulls A Takeover Deal
NVS

Investor's Business Daily

2 days ago

Avidity Biosciences Rockets As Novartis Reportedly Mulls A Takeover Deal

NVS

MT Newswires

2 days ago

Sector Update: Health Care Stocks Slide Late Afternoon

NVS

MT Newswires

2 days ago

Sector Update: Health Care Stocks Fall Wednesday Afternoon

NVS

MT Newswires

2 days ago

Sector Update: Health Care

Teva’s Ajovy becomes first migraine prevention drug approved for children
NVS

Pharmaceutical Technology

2 days ago

Teva’s Ajovy becomes first migraine prevention drug approved for children

Cell Line Development Market Outlook Report 2025-2034: PromoCell, Novartis, Genscript Biotech, Sartorius, and Thermo Fisher Scientific Dominate the Industry
NVS

GlobeNewswire

2 days ago

Cell Line Development Market Outlook Report 2025-2034: PromoCell, Novartis, Genscript Biotech, Sartorius, and Thermo Fisher Scientific Dominate the Industry

American Kidney Fund Expands ‘Me + C3G’ Campaign with New Resources to Help Patients Living with this Rare Kidney Disease
NVS

GlobeNewswire

2 days ago

American Kidney Fund Expands ‘Me + C3G’ Campaign with New Resources to Help Patients Living with this Rare Kidney Disease

United States Smart Pills Market Research and Company Analysis Report 2025-2033 Featuring Check-Cap, General Electric, Fujifilm, Koninklijke Philips, Medtronic, Olympus, Novartis, Otsuka
NVS

GlobeNewswire

3 days ago

United States Smart Pills Market Research and Company Analysis Report 2025-2033 Featuring Check-Cap, General Electric, Fujifilm, Koninklijke Philips, Medtronic, Olympus, Novartis, Otsuka

Saudi Arabia Vision Care Market Forecast and Company Analysis Report 2025-2033 Featuring Essilor, J&J, Bausch Health, Novartis, Grand Vision, Carl Zeiss, Valeant, Paragon Vision Science, Menicon
NVS

GlobeNewswire

3 days ago

Saudi Arabia Vision Care Market Forecast and Company Analysis Report 2025-2033 Featuring Essilor, J&J, Bausch Health, Novartis, Grand Vision, Carl Zeiss, Valeant, Paragon Vision Science, Menicon

[Latest] Global Paracetamol Market Size/Share Worth USD 1460.23 Million by 2034 at a 5.24% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
NVS

GlobeNewswire

4 days ago

[Latest] Global Paracetamol Market Size/Share Worth USD 1460.23 Million by 2034 at a 5.24% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Will These 5 Pharma, Biotech Bigwigs Surpass Q2 Earnings Forecasts?
NVS

Zacks

4 days ago

Will These 5 Pharma, Biotech Bigwigs Surpass Q2 Earnings Forecasts?

Swiss Stocks Decline on US Tariffs, Push for Lower Drug Prices
NVS

Bloomberg

4 days ago

Swiss Stocks Decline on US Tariffs, Push for Lower Drug Prices

Swiss Gird for Stocks to Fall as Markets Reopen After Tariff Hit
NVS

Bloomberg

5 days ago

Swiss Gird for Stocks to Fall as Markets Reopen After Tariff Hit

Apellis Pharmaceuticals (APLS) Surges 17.6% on Higher Price Target
NVS

Insider Monkey

7 days ago

Apellis Pharmaceuticals (APLS) Surges 17.6% on Higher Price Target

ALNY Q2 Earnings Top Estimates on Higher Amvuttra Revenues, Stock Up
NVS

Zacks

7 days ago

ALNY Q2 Earnings Top Estimates on Higher Amvuttra Revenues, Stock Up

Switzerland, the land of luxury brands, could see prices skyrocket from Trump's 39% tariffs
NVS

Associated Press Finance

7 days ago

Switzerland, the land of luxury brands, could see prices skyrocket from Trump's 39% tariffs

Global Pharma Stocks Fall After Trump Demands Cuts in Drug Prices
NVS

The Wall Street Journal

7 days ago

Global Pharma Stocks Fall After Trump Demands Cuts in Drug Prices

Trump Unleashes Massive Tariffs on Swiss Watches, Pharma Firms
NVS

Bloomberg

7 days ago

Trump Unleashes Massive Tariffs on Swiss Watches, Pharma Firms

Trump doubles down on Most Favored Nation plan to target drug prices
NVS

Pharmaceutical Technology

8 days ago

Trump doubles down on Most Favored Nation plan to target drug prices

Novartis twice-yearly* Leqvio® (inclisiran) receives FDA approval for new indication enabling first-line use
NVS

PR Newswire

8 days ago

Novartis twice-yearly* Leqvio® (inclisiran) receives FDA approval for new indication enabling first-line use

What Trump's Big Pharma CEO letters mean for drug pricing power
NVS

Yahoo Finance Video

8 days ago

What Trump's Big Pharma CEO letters mean for drug pricing power

Trump Sends Letters to 17 Pharmaceutical Companies Asking Them to Lower Costs
NVS

The Wall Street Journal

8 days ago

Trump Sends Letters to 17 Pharmaceutical Companies Asking Them to Lower Costs

NVS

Morningstar Research

8 days ago

Analyst Report: Haleon plc

Ionis Beats on Q2 Earnings & Sales, Stock Up 5% on Raised '25 Outlook
NVS

Zacks

8 days ago

Ionis Beats on Q2 Earnings & Sales, Stock Up 5% on Raised '25 Outlook

Renal Failure Clinical Trials Market Landscape Report 2025 Featuring Bayer, AstraZeneca, Amgen, Sanofi, Novartis, AbbVie, Roche, Pfizer, Takeda, Astellas
NVS

GlobeNewswire

8 days ago

Renal Failure Clinical Trials Market Landscape Report 2025 Featuring Bayer, AstraZeneca, Amgen, Sanofi, Novartis, AbbVie, Roche, Pfizer, Takeda, Astellas

Multiple Sclerosis Clinical Trials Market Landscape Report 2025 Featuring Biogen, Novartis, Sanofi, Merck, Teva, Bayer, Roche, Bristol-Myers Squibb, Laboratory Corp of America, IQVIA
NVS

GlobeNewswire

8 days ago

Multiple Sclerosis Clinical Trials Market Landscape Report 2025 Featuring Biogen, Novartis, Sanofi, Merck, Teva, Bayer, Roche, Bristol-Myers Squibb, Laboratory Corp of America, IQVIA

Systemic Lupus Erythematosus Clinical Trials Market Landscape Report 2025 Featuring GSK, BMS, AstraZeneca, Thermo Fisher Scientific, ICON, IQVIA, Parexel, Laboratory Corp of America, Novartis, Pfizer
NVS

GlobeNewswire

8 days ago

Systemic Lupus Erythematosus Clinical Trials Market Landscape Report 2025 Featuring GSK, BMS, AstraZeneca, Thermo Fisher Scientific, ICON, IQVIA, Parexel, Laboratory Corp of America, Novartis, Pfizer

Sicca Syndrome (Sjogren) Clinical Trials Market Landscape Report 2025 Featuring Novartis, BMS, ICON, AbbVie, Parexel, Thermo Fisher Scientific, Amgen, Laboratory Corp of America, IQVIA, Syneos Health
NVS

GlobeNewswire

8 days ago

Sicca Syndrome (Sjogren) Clinical Trials Market Landscape Report 2025 Featuring Novartis, BMS, ICON, AbbVie, Parexel, Thermo Fisher Scientific, Amgen, Laboratory Corp of America, IQVIA, Syneos Health

Mycosis Fungoides Clinical Trials Market Landscape Report 2025 Featuring Pfizer, Bristol-Myers Squibb, Kirin, Takeda, Johnson & Johnson, Merck, Soligenix, Eisai, Novartis, ICON
NVS

GlobeNewswire

8 days ago

Mycosis Fungoides Clinical Trials Market Landscape Report 2025 Featuring Pfizer, Bristol-Myers Squibb, Kirin, Takeda, Johnson & Johnson, Merck, Soligenix, Eisai, Novartis, ICON

Glaucoma Global Clinical Trials Market Landscape Report 2025 Featuring Alcon, AbbVie, Santen Pharmaceutical, Pfizer, Kowa, Viatris, Merck, Novartis, Senju Pharmaceutical, Bausch Health
NVS

GlobeNewswire

8 days ago

Glaucoma Global Clinical Trials Market Landscape Report 2025 Featuring Alcon, AbbVie, Santen Pharmaceutical, Pfizer, Kowa, Viatris, Merck, Novartis, Senju Pharmaceutical, Bausch Health

NVS

Morningstar Research

10 days ago

Analyst Report: Incyte Corporation

INCY's Q2 Earnings & Revenues Beat Estimates on Higher Product Sales
NVS

Zacks

10 days ago

INCY's Q2 Earnings & Revenues Beat Estimates on Higher Product Sales

Radiopharma startup Artbio secures $132M to fund testing of Pluvicto rival
NVS

BioPharma Dive

10 days ago

Radiopharma startup Artbio secures $132M to fund testing of Pluvicto rival

HS market forecast to reach $7.8bn across 7MM by 2034
NVS

Pharmaceutical Technology

11 days ago

HS market forecast to reach $7.8bn across 7MM by 2034

Will These 5 Pharma/Biotech Bigwigs Surpass Q2 Earnings Forecasts?
NVS

Zacks

11 days ago

Will These 5 Pharma/Biotech Bigwigs Surpass Q2 Earnings Forecasts?

AAV for the Hereditary Retinal Diseases Market Competitive Landscape Report 2025 | Novartis, MeiraGTx, 4D Molecular Therapeutics, and Beacon Therapeutics Lead the Charge in Innovative Therapies
NVS

GlobeNewswire

11 days ago

AAV for the Hereditary Retinal Diseases Market Competitive Landscape Report 2025 | Novartis, MeiraGTx, 4D Molecular Therapeutics, and Beacon Therapeutics Lead the Charge in Innovative Therapies

Myeloproliferative Disorder Treatment Market Insights, Competitive Landscape, and Forecast Report 2025-2032 Featuring Novartis, Incyte, Bristol Myers Squibb, CTI BioPharma, GSK, PharmaEssentia
NVS

GlobeNewswire

14 days ago

Myeloproliferative Disorder Treatment Market Insights, Competitive Landscape, and Forecast Report 2025-2032 Featuring Novartis, Incyte, Bristol Myers Squibb, CTI BioPharma, GSK, PharmaEssentia

Post-Operative Nausea and Vomiting Market Report 2025: Surge in Surgical Procedures Fuels $2.97 Billion Growth in PONV Market by 2029
NVS

GlobeNewswire

14 days ago

Post-Operative Nausea and Vomiting Market Report 2025: Surge in Surgical Procedures Fuels $2.97 Billion Growth in PONV Market by 2029

Incyte Gears Up to Report Q2 Earnings: Is a Beat in the Cards?
NVS

Zacks

15 days ago

Incyte Gears Up to Report Q2 Earnings: Is a Beat in the Cards?

Fibroblast Growth Factors (FGFs) Global Market Report 2025-2029 & 2034 | Regenerative Medicine Demand and Biotech Advancements Fueling Expansion
NVS

GlobeNewswire

15 days ago

Fibroblast Growth Factors (FGFs) Global Market Report 2025-2029 & 2034 | Regenerative Medicine Demand and Biotech Advancements Fueling Expansion

NVS

MT Newswires

15 days ago

Novartis to Pay Matchpoint Up to $1 Billion to Develop Anti-Inflammatory Treatments

Here's Why Novartis (NVS) is a Strong Value Stock
NVS

Zacks

15 days ago

Here's Why Novartis (NVS) is a Strong Value Stock

Arvinas, Inc. (ARVN): A Bull Case Theory
NVS

Insider Monkey

15 days ago

Arvinas, Inc. (ARVN): A Bull Case Theory

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
NVS

Zacks

15 days ago

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings

Novartis to pay Matchpoint up to $1 billion to develop anti-inflammatory therapies
NVS

Reuters

15 days ago

Novartis to pay Matchpoint up to $1 billion to develop anti-inflammatory therapies

Matchpoint Therapeutics Announces Exclusive Option and License Agreement with Novartis to Develop Oral Inhibitors for Multiple Inflammatory Diseases
NVS

GlobeNewswire

15 days ago

Matchpoint Therapeutics Announces Exclusive Option and License Agreement with Novartis to Develop Oral Inhibitors for Multiple Inflammatory Diseases

Behcet's Disease Market Research Report 2025-2035 | Key Trends, Regulatory Framework, Epidemiology, Clinical Trial Analysis, Market Dynamics
NVS

GlobeNewswire

15 days ago

Behcet's Disease Market Research Report 2025-2035 | Key Trends, Regulatory Framework, Epidemiology, Clinical Trial Analysis, Market Dynamics

Tinnitus Market Analysis and Forecast Report 2025-2035 | Pharma Giants Drive Treatment Advances with Off-Label CNS Drugs Amid Intensifying Market Competition
NVS

GlobeNewswire

15 days ago

Tinnitus Market Analysis and Forecast Report 2025-2035 | Pharma Giants Drive Treatment Advances with Off-Label CNS Drugs Amid Intensifying Market Competition

Benign Breast Disease and Early Breast Cancer Market Analysis Report 2025-2035 | Key Emerging Trends That are Reshaping the Landscape of Diagnosis, Treatment, and Patient Care
NVS

GlobeNewswire

15 days ago

Benign Breast Disease and Early Breast Cancer Market Analysis Report 2025-2035 | Key Emerging Trends That are Reshaping the Landscape of Diagnosis, Treatment, and Patient Care

CAR T-Cell Therapy Market Trends and Forecasts, 2021-2024 & 2025-2033 | Focus on Yescarta, Tecartus, Kymriah, Breyanzi, Abecma, Carvykti, and Carteyva
NVS

GlobeNewswire

15 days ago

CAR T-Cell Therapy Market Trends and Forecasts, 2021-2024 & 2025-2033 | Focus on Yescarta, Tecartus, Kymriah, Breyanzi, Abecma, Carvykti, and Carteyva

Novartis' (VTX:NOVN) Performance Is Even Better Than Its Earnings Suggest
NVS

Simply Wall St.

16 days ago

Novartis' (VTX:NOVN) Performance Is Even Better Than Its Earnings Suggest

Epilepsy Drugs Market Growth Analysis, Forecast Trends and Outlook Report 2025-2034 | Demand for Generic Epilepsy Drugs Rises as Patent Expirations Fuel Market Growth
NVS

GlobeNewswire

16 days ago

Epilepsy Drugs Market Growth Analysis, Forecast Trends and Outlook Report 2025-2034 | Demand for Generic Epilepsy Drugs Rises as Patent Expirations Fuel Market Growth

Analysis Group Co-Authors Examine the Advancements in and Application of Health Economics and Outcomes Research to the Evaluation of Cell and Gene Therapies for Rare Diseases
NVS

PR Newswire

17 days ago

Analysis Group Co-Authors Examine the Advancements in and Application of Health Economics and Outcomes Research to the Evaluation of Cell and Gene Therapies for Rare Diseases

AZN Commits USD50B to US Manufacturing Expansion Amid Tariff Pressures
NVS

Zacks

17 days ago

AZN Commits USD50B to US Manufacturing Expansion Amid Tariff Pressures

Novartis AG (NVS): Jim Cramer Wonders Whether Its CEO Is Leaving [UPDATED]
NVS

Insider Monkey

17 days ago

Novartis AG (NVS): Jim Cramer Wonders Whether Its CEO Is Leaving [UPDATED]

AstraZeneca Plans to Invest $50B in US Manufacturing and Research by 2030
NVS

Investopedia

17 days ago

AstraZeneca Plans to Invest $50B in US Manufacturing and Research by 2030

Health Care Roundup: Market Talk
NVS

The Wall Street Journal

17 days ago

Health Care Roundup: Market Talk

Should You Invest in the VanEck Pharmaceutical ETF (PPH)?
NVS

Zacks

17 days ago

Should You Invest in the VanEck Pharmaceutical ETF (PPH)?

Novartis’ Zolgensma sales fall again as gene therapy market woes persist
NVS

Pharma Voice

17 days ago

Novartis’ Zolgensma sales fall again as gene therapy market woes persist

NYC Council's Firewall Starts in District 5--with a Bombshell Named Alina
NVS

PR Newswire

18 days ago

NYC Council's Firewall Starts in District 5--with a Bombshell Named Alina

Kisqali Emerges as Novartis AG (NVS) Blockbuster with Record Q2 Growth
NVS

Insider Monkey

18 days ago

Kisqali Emerges as Novartis AG (NVS) Blockbuster with Record Q2 Growth

Betting Big on Cancer: 3 Oncology Stocks Set to Surge in 2025
NVS

Zacks

18 days ago

Betting Big on Cancer: 3 Oncology Stocks Set to Surge in 2025

NVS

Argus Research

18 days ago

Analyst Report: Novartis AG

NVS

Argus Research

18 days ago

Market Digest: NVS, TFC, FAST, HBAN, NFLX, PWR, SCHW, ELV

Industry-Wide Tariffs Loom Over the Healthcare Sector. Here Are 2 Stocks That Can Weather the Storm.
NVS

Motley Fool

19 days ago

Industry-Wide Tariffs Loom Over the Healthcare Sector. Here Are 2 Stocks That Can Weather the Storm.

Novartis AG (VTX:NOVN) Just Reported Second-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
NVS

Simply Wall St.

20 days ago

Novartis AG (VTX:NOVN) Just Reported Second-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

NVS

Morningstar Research

21 days ago

Analyst Report: Novartis AG

Buy These 5 Low-Leverage Stocks Amid Impressive Retail Sales Data
NVS

Zacks

21 days ago

Buy These 5 Low-Leverage Stocks Amid Impressive Retail Sales Data

Epilepsy Therapeutics Market Trends, Competitive Strategies and Forecasts Report 2025-2033 | Personalized Medicine Paves New Pathways in Treatment, Third-Generation Therapeutics Lead Growth
NVS

GlobeNewswire

21 days ago

Epilepsy Therapeutics Market Trends, Competitive Strategies and Forecasts Report 2025-2033 | Personalized Medicine Paves New Pathways in Treatment, Third-Generation Therapeutics Lead Growth

Adult-onset Still Disease Market Research Report 2025-2035 | Personalized Medicine and Biomarker Discoveries Enhance Treatment Outcomes
NVS

GlobeNewswire

21 days ago

Adult-onset Still Disease Market Research Report 2025-2035 | Personalized Medicine and Biomarker Discoveries Enhance Treatment Outcomes

Novartis culls ianalumab in HS after Phase IIb trial failure
NVS

Clinical Trials Arena

21 days ago

Novartis culls ianalumab in HS after Phase IIb trial failure

Novartis AG (NVS) Q2 2025 Earnings Call Highlights: Strong Growth and Strategic Initiatives ...
NVS

GuruFocus.com

21 days ago

Novartis AG (NVS) Q2 2025 Earnings Call Highlights: Strong Growth and Strategic Initiatives ...

NVS

Morningstar Research

22 days ago

Analyst Report: Novartis AG

Novartis Sacrifices A Breakout As One Of Its Bread-And-Butter Drugs Misses
NVS

Investor's Business Daily

22 days ago

Novartis Sacrifices A Breakout As One Of Its Bread-And-Butter Drugs Misses

NVS

MT Newswires

22 days ago

Sector Update: Health Care Stocks Fall Late Afternoon

Novartis CEO on Psoriasis Drug, China Growth, Tariffs, M&A
NVS

Bloomberg

22 days ago

Novartis CEO on Psoriasis Drug, China Growth, Tariffs, M&A

Diverging Treatment Goals Emerge Between Hematologists and Nephrologists in aHUS Care, According to Spherix Global Insights
NVS

GlobeNewswire

22 days ago

Diverging Treatment Goals Emerge Between Hematologists and Nephrologists in aHUS Care, According to Spherix Global Insights

Novartis Makes A Bearish Move As One Of Its Bread-And-Butter Drugs Misses
NVS

Investor's Business Daily

22 days ago

Novartis Makes A Bearish Move As One Of Its Bread-And-Butter Drugs Misses

Novartis Trims Operating Income Outlook After Strong Q2 Performance, Initiates $10 Billion Stock Buyback
NVS

Benzinga

22 days ago

Novartis Trims Operating Income Outlook After Strong Q2 Performance, Initiates $10 Billion Stock Buyback

Trump & Coca-Cola, Novartis earnings, Netflix preview: Trending Tickers
NVS

Yahoo Finance Video

22 days ago

Trump & Coca-Cola, Novartis earnings, Netflix preview: Trending Tickers

Stocks Mostly Up Pre-Bell as Trump Denies Speculation About Firing Fed Chair Powell; Corporate Earnings on Deck
NVS

MT Newswires

22 days ago

Stocks Mostly Up Pre-Bell as Trump Denies Speculation About Firing Fed Chair Powell; Corporate Earnings on Deck

Health Care Roundup: Market Talk
NVS

The Wall Street Journal

22 days ago

Health Care Roundup: Market Talk

Novartis Reports Mixed Second-Quarter Results; Maintains Full-Year Sales Growth Outlook
NVS

MT Newswires

22 days ago

Novartis Reports Mixed Second-Quarter Results; Maintains Full-Year Sales Growth Outlook

Novartis first half net profits up 29 percent
NVS

AFP

22 days ago

Novartis first half net profits up 29 percent

NVS

Investing.com

23 days ago

Novartis fails to block MSN from selling generic heart drug Entresto

Thermo Fisher acquires Sanofi's New Jersey manufacturing site
NVS

Reuters

23 days ago

Thermo Fisher acquires Sanofi's New Jersey manufacturing site

Trump threatens tariffs on medicines within weeks
NVS

The Telegraph

23 days ago

Trump threatens tariffs on medicines within weeks

Trump Threatens Pharma Tariffs This Month. Why the Stocks Are Looking Healthy.
NVS

Barrons.com

23 days ago

Trump Threatens Pharma Tariffs This Month. Why the Stocks Are Looking Healthy.

3 Medical Stocks to Watch as Q2 Earnings Approach: ABT, JNJ, NVS
NVS

Zacks

24 days ago

3 Medical Stocks to Watch as Q2 Earnings Approach: ABT, JNJ, NVS

Will Key Drugs Maintain Momentum for Novartis in Q2 Earnings?
NVS

Zacks

24 days ago

Will Key Drugs Maintain Momentum for Novartis in Q2 Earnings?

Inflation Data and Bank Earnings Kick Off a Crucial Test for Markets
NVS

The Daily Upside

24 days ago

Inflation Data and Bank Earnings Kick Off a Crucial Test for Markets

Bayer Gets FDA Nod for Label Expansion of Kerendia in Heart Failure
NVS

Zacks

25 days ago

Bayer Gets FDA Nod for Label Expansion of Kerendia in Heart Failure

Exploring Analyst Estimates for Novartis (NVS) Q2 Earnings, Beyond Revenue and EPS
NVS

Zacks

25 days ago

Exploring Analyst Estimates for Novartis (NVS) Q2 Earnings, Beyond Revenue and EPS

Novartis AG (VTX:NOVN) On An Uptrend: Could Fundamentals Be Driving The Stock?
NVS

Simply Wall St.

25 days ago

Novartis AG (VTX:NOVN) On An Uptrend: Could Fundamentals Be Driving The Stock?

What To Expect in Markets This Week: Big Bank Earnings, June Inflation, Retail Sales Data
NVS

Investopedia

a month ago

What To Expect in Markets This Week: Big Bank Earnings, June Inflation, Retail Sales Data

FDA willing to trade faster drug reviews for lower prices, Bloomberg reports
NVS

TipRanks

a month ago

FDA willing to trade faster drug reviews for lower prices, Bloomberg reports

Portfolio manager sees long-term AI upside in healthcare sector
NVS

Reuters Videos

a month ago

Portfolio manager sees long-term AI upside in healthcare sector

NVS

MT Newswires

a month ago

Sector Update: Health Care Stocks Retreat Late Afternoon

Share on Social Networks: